Hereditary diffuse gastric cancer

Principles of Clinical Cancer Genetics: A Handbook from the Massachusetts General Hospital

Volumn , Issue , 2010, Pages 97-107

  Pandalai, Prakash K ^a   Yoon, Sam S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

CDH1 gene; Diffuse gastric cancer; E cadherin; Endoscopy; Gastrectomy; Lobular breast cancer; Signet ring cells

Indexed keywords

EID: 79955465957     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-93846-2_8     Document Type: Chapter

References (76)

1. Lee J et al (2007) Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea. Cancer Control 14(1):78-85
2. Jemal A et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2): 71-96
3. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12(3):354-362
4. Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 64:31-49
5. Lynch HT et al (2005) Gastric cancer: new genetic developments. J Surg Oncol 90(3):114-133, discussion 133
6. Karpeh MS, Kelsen DP, Tepper JE (2001) Cancer of the stomach. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1092-1126
7. Sasazuki S, Sasaki S, Tsugane S (2002) Cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subsite and histologic type. Int J Cancer 101(6):560-566
8. Kobayashi M et al (2002) Vegetables, fruit and risk of gastric cancer in Japan: a 10-year follow-up of the JPHC Study Cohort I. Int J Cancer 102(1):39-44
9. Serafini M et al (2002) Total antioxidant potential of fruit and vegetables and risk of gastric cancer. Gastroenterology 123(4):985-991
10. Jones EG (1964) Familial gastric cancer. N Z Med J 63:287-296
11. Guilford P et al (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392(6674):402-405
12. Guilford PJ et al (1999) E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 14(3):249-255
13. Gayther SA et al (1998) Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 58(18):4086-4089
14. Kaurah P et al (2007) Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 297(21): 2360-2372
15. Richards FM et al (1999) Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.Hum Mol Genet 8(4):607-610
16. Park JG et al (2000) Report on the first meeting of the International Collaborative Group on Hereditary Gastric Cancer. J Natl Cancer Inst 92(21):1781-1782
17. Pedrazzani C et al (2007) E-cadherin and hereditary diffuse gastric cancer. Surgery 142(5):645-657
18. Brooks-Wilson AR et al (2004) Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 41(7):508-517
19. Oliveira C et al (2009) Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 18(9):1545-1555
20. Berx G et al (1995) E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14(24): 6107-6115
21. Grunwald GB (1993) The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules. Curr Opin Cell Biol 5(5):797-805
22. Chan AO (2006) E-cadherin in gastric cancer. World J Gastroenterol 12(2):199-203
23. Becker KF et al (1994) E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54(14):3845-3852
24. Grady WM et al (2000) Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 26(1):16-17
25. Keller G et al (1999) Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol 155(2):337-342
26. Schrader KA et al (2008) Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer 7(1):73-82
27. Norton JA et al (2007) CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann Surg 245(6):873-879
28. Birchmeier W (1995) E-cadherin as a tumor (invasion) suppressor gene. Bioessays 17(2):97-99
29. Birchmeier W, Hulsken J, Behrens J (1995) E-cadherin as an invasion suppressor. Ciba Found Symp 189:124-136, discussion 136-141, 174-176
30. Carneiro F et al (1999) E-cadherin changes in gastric carcimona. Histopathology 35(5):477-478
31. Oliveira C et al (2009) Quantification of epigenetic and genetic second hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 136(7):2137-2148.
32. Machado JC et al (2001) E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20(12):1525-1528
33. Oliveira C et al (2004) Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour. Oncogene 23(12):2236-2240
34. Tamura G et al (2000) E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92(7):569-573
35. Graziano F et al (2004) Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer. Clin Cancer Res 10(8): 2784-2789
36. Graziano F et al (2004) Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs. Ann Oncol 15(3):489-492
37. Suriano G et al (2003) E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. Hum Mol Genet 12(22): 3007-3016
38. Suriano G et al (2003) The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion. Oncogene 22(36):5716-5719
39. Suriano G et al (2005) Beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer. Genes Chromosomes Cancer 42(3):238-246
40. Oliveira C et al (2004) E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. Eur J Cancer 40(12):1897-1903
41. Caldas C et al (1999) Familial gastric cancer: overview and guidelines for management. J Med Genet 36(12):873-880
42. Pharoah PD, Guilford P, Caldas C (2001) Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121(6): 1348-1353
43. Vasen HF et al (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110(4):1020-1027
44. Aarnio M et al (1997) Features of gastric cancer in hereditary nonpolyposis colorectal cancer syndrome. Int J Cancer 74(5):551-555
45. Giardiello FM et al (2000) Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119(6):1447-1453
46. Masciari S et al (2007) Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet 44(11):726-731
47. Oliveira C, Seruca R, Caldas C (2003) Genetic screening for hereditary diffuse gastric cancer. Expert Rev Mol Diagn 3(2):201-215
48. Suriano G et al (2005) Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res 11(15):5401-5409
49. Mullins FM et al (2007) Identification of an intronic single nucleotide polymorphism leading to allele dropout during validation of a CDH1 sequencing assay: implications for designing polymerase chain reaction-based assays. Genet Med 9(11):752-760
50. Charlton A et al (2004) Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut 53(6):814-820
51. Huntsman DG et al (2001) Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 344(25):1904-1909
52. Blair V et al (2006) Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol 4(3):262-275
53. Tatsuta M et al (1982) Endoscopic diagnosis of early gastric cancer by the endoscopic Congo red-methylene blue test. Cancer 50(12): 2956-2960
54. Iishi H, Tatsuta M, Okuda S (1988) Diagnosis of simultaneous multiple gastric cancers by the endoscopic Congo red-methylene blue test. Endoscopy 20(2):78-82
55. Shaw D et al (2005) Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Gut 54(4):461-468
56. Barber ME et al (2008) Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. J Pathol 216(3):286-294
57. van Kouwen MC et al (2004) [18F]Fluoro-2-deoxy-d-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier. Clin Cancer Res 10(19):6456-6459
58. Yamada A et al (2006) Evaluation of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter- 1 expression. Ann Nucl Med 20(9):597-604
59. Chung DC et al (2007) Case records of the Massachusetts General Hospital. Case 22-2007. A woman with a family history of gastric and breast cancer. N Engl J Med 357(3):283-291
60. Chun YS et al (2001) Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? Cancer 92(1):181-187
61. Lewis FR et al (2001) Prophylactic total gastrectomy for familial gastric cancer. Surgery 130(4):612-617, discussion 617-619
62. Rogers WM et al (2008) Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Am J Surg Pathol 32(6):799-809
63. Hartgrink HH et al (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22(11):2069-2077
64. Park DJ et al (2005) Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg 92(9):1099-1102
65. Wanebo HJ et al (1993) Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 218(5): 583-592
66. Fujimoto S et al (1991) Stapled or manual suturing in esophagojejunostomy after total gastrectomy: a comparison of outcome in 379 patients. Am J Surg 162(3):256-259
67. Seufert RM, Schmidt-Matthiesen A, Beyer A (1990) Total gastrectomy and oesophagojejunostomy - a prospective randomized trial of hand-sutured versus mechanically stapled anastomoses. Br J Surg 77(1):50-52
68. Hyodo M et al (2007) Minimum leakage rate (0.5%) of stapled esophagojejunostomy with sacrifice of a small part of the jejunum after total gastrectomy in 390 consecutive patients. Dig Surg 24(3):169-172
69. Donovan IA et al (1982) Bile diversion after total gastrectomy. Br J Surg 69(7):389-390
70. Lehnert T, Buhl K (2004) Techniques of reconstruction after total gastrectomy for cancer. Br J Surg 91(5):528-539
71. Fein M et al (2008) Long-term benefits of Roux-en-Y pouch reconstruction after total gastrectomy: a randomized trial. Ann Surg 247(5):759-765
72. Roviello F et al (2007) High incidence of familial gastric cancer in Tuscany, a region in Italy. Oncology 72(3-4):243-247
73. Dulucq JL et al (2005) Completely laparoscopic total and partial gastrectomy for benign and malignant diseases: a single institute's prospective analysis. J Am Coll Surg 200(2):191-197
74. Usui S et al (2005) Laparoscopy-assisted total gastrectomy for early gastric cancer: comparison with conventional open total gastrectomy. Surg Laparosc Endosc Percutan Tech 15(6):309-314
75. Miholic J et al (1990) Nutritional consequences of total gastrectomy: the relationship between mode of reconstruction, postprandial symptoms, and body composition. Surgery 108(3): 488-494
76. Francis A et al (2001) The diagnosis of invasive lobular breast carcinoma.Does MRI have a role? Breast 10(1):38-40